DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hexabrix (Ioxaglate Meglumine / Ioxaglate Sodium) - Published Studies

 
 



Hexabrix Related Published Studies

Well-designed clinical trials related to Hexabrix (Ioxaglate)

Dimenhydrinate pretreatment in patients receiving intra-arterial ioxaglate: effect on nausea and vomiting. [1995.12]

Immediate and delayed tolerance of iohexol and ioxaglate in lower limb phlebography: a double-blind comparative study in humans. [1995.08]

Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml. [1994.11]

[The mechanism producing nausea during ventriculography performed with ioxaglate: the implications of a randomized study] [1994.11]

A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography. [1993.11]

Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. [1993.10]

Double-blind comparison of the clinical, hemodynamic, and electrocardiographic effects of sodium meglumine ioxaglate or iohexol during diagnostic cardiac catheterization. [1992.09]

Granulocyte adherence after intravenous and intraarterial injection of ioxaglate or iohexol. [1992.09]

The effects of ioxaglate 320, iohexol 350, and iopamidol 370 on erythrocyte aggregation. [1991.08]

Iohexol, ioxaglate and iopamidol in coronary angiography. A double-blind comparative study of 300 patients. [1991.05]

The effects of high (sodium meglumine diatrizoate, Renografin-76) and low osmolar (sodium meglumine ioxaglate, Hexabrix) radiographic contrast media on diastolic function during left ventriculography in patients. [1991.03]

Influence of low osmolality contrast media on electrophysiology and hemodynamics in coronary angiography: differences between an ionic (ioxaglate) and a nonionic (iohexol) agent. [1990.12]

Are ioxaglate and iopamidol equally safe and well tolerated in cardiac angiography? A randomized, double-blind clinical study. [1990.11]

A multicenter randomized trial of ionic (ioxaglate) and nonionic (iopamidol) low-osmolality contrast agents in cardiac angiography. [1989.12]

Comparison of Hexabrix 320 and Hexabrix 250 in aortoperipheral arteriography: towards cheaper low osmolar contrast media? [1989.05]

Comparison of low osmolality ionic (ioxaglate) versus nonionic (iopamidol) contrast media in cardiac angiography. [1989.02.15]

Demonstration of splenic and portal veins at routine celiac angiography. A clinical investigation of metrizoate and ioxaglate. [1989.01]

Well-designed clinical trials possibly related to Hexabrix (Ioxaglate)

Preventing acute decrease in renal function induced by coronary angiography (PRECORD): a prospective randomized trial. [2009.11]

A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. [2006.08]

Renal effects of CO2 and iodinated contrast media in patients undergoing renovascular intervention: a prospective, randomized study. [2005.01]

[Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography] [2003.12]

Hemodynamic effects and image quality of low-osmolar ionic and nonionic contrast media during pulmonary angiography. [1995.07]

Effects of monoionic and nonionic radiographic contrast media on cutaneous microcirculation in patients with peripheral arterial occlusive disease. [1995.07]

Allergic-type adverse reactions to low osmolality contrast media in patients with a history of allergy or asthma. [1995.05]

Increased plasma levels of PAI-1 after administration of nonionic contrast medium in patients undergoing pulmonary angiography. [1994.12]

[Electron microscopic comparison of the antithrombotic potential of 2 low osmolality iodine contrast media in percutaneous transluminal coronary angioplasty] [1994.02]

Effect of radiographic contrast media on granulocyte phagocytosis of Escherichia coli in a whole blood flow cytometric assay. [1994.01]

[Comparative thrombotic risk of two contrast agents in coronary angiography] [1994]

Effects of an ionic versus a nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty. [1993.02]

Variation in hemostatic parameters after intra-arterial and intravenous administration of iodinated contrast media. [1992.12]

[Effects of contrast media under systemic heparinization on blood coagulation and fibrinolytic system during angiocardiography--comparison of ionic and nonionic contrast media] [1992.08.25]

Comparative randomized double-blind study of hydroxyzine versus placebo as premedication before injection of iodinated contrast media. [1992.08]

Adverse reactions of low osmolality contrast media during cardiac angiography: a prospective randomized multicenter study. [1992.04]

The effects of ionic and nonionic radiographic contrast media on coronary hyperemia in patients during coronary angiography. [1992.03]

Leukotriene B4 and peptido-leukotriene levels during radiographic contrast media infusion. [1992.03]

Risk of thrombosis during coronary angioplasty with low osmolality contrast media. [1991.10.15]

A comparative study of contrast agents for endoscopic retrograde pancreatography. [1991.10]

In vivo effects of nonionic and ionic contrast media on beta-thromboglobulin and fibrinopeptide levels. [1991.06]

Plasma osmolality, iodine concentration and urographic images following high and low osmolar contrast media. [1991.05]

Therapeutic effect of hysterosalpingography: oil- versus water-soluble contrast media--a randomized prospective study. [1991.04]

Diagnostic quality and complications of hysterosalpingography: oil- versus water-soluble contrast media--a randomized prospective study. [1991.04]

Comparison of ionic and non-ionic contrast agents in cardiac catheterization: the effects of ventriculography and coronary arteriography on hemodynamics, electrocardiography, and serum creatinine. [1991.04]

[Comparison of thrombogenic risk between teflon and polyethylene in prolonged catheterization of the radial artery] [1991]

Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: comparison of low- and high-osmolar contrast agents. [1991]

[Risk of thrombosis in prolonged catheterization of the radial artery: comparison of 2 types of catheters] [1990]

A comparative study to evaluate the role of intra-articular adrenaline in double-contrast knee arthrography. [1989.11]

Other research related to Hexabrix (Ioxaglate)

Torsade de pointes induced by ioxaglate intracoronary injection in patients with pre-existent drug-induced QT prolongation: case reports and review of literature. [2011.06]

Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. [2006.09.05]

The ionic contrast medium ioxaglate interferes with thrombin-mediated feedback activation of factor V, factor VIII and platelets. [2003.02]

In vivo comparative antithrombotic effects of ioxaglate and iohexol and interaction with the platelet antiaggregant clopidogrel. [2003.01]

Differential effects of the iodinated contrast agents Ioxaglate, Iohexol and Iodixanol on thrombus formation and fibrinolysis. [2003]

A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention. [2002.11]

Allergic reactions at repeat femoral angiography with ioxaglate. [2001.11]

Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. [2001.04]

Vectorcardiographic changes during cardioangiography with iodixanol and ioxaglate. [2000.11]

A comparison of the efficacy and safety of ioxaglate and iobitridol in renal angioplasty. [2000.03]

Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators. [2000.01.18]

[Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study] [1999.07]

A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. [1999.02]

Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate. [1998.07]

[Blood cell count, sodium, potassium, calcium, osmolality and viscosity during pediatric angiocardiography with ioxaglate] [1998.04]

Iopentol (Imagopaque 300) compared with ioxaglate (Hexabrix 320) in knee arthrography. A clinical trial assessing immediate and late adverse events and diagnostic information. [1997]

Polymorphic ventricular tachycardia induced by intracoronary injection of ioxaglate in a patient with borderline QT prolongation. [1996.10]

[Comparison between iopamidol and ioxaglate in digital arteriography of the lower limbs] [1996.09]

Iodixanol and ioxaglate in adult aortography and peripheral arteriography: a phase III clinical trial. [1996.09]

Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trial. [1996.09]

Iohexol vs. ioxaglate in lower extremity angiography: a comparative randomized double-blind study in 80 patients. [1996.05]

[Contrast media in peripheral angiography: does cost reduction mean loss of quality and safety? A reevaluation based on a randomized double-blind comparative study of ioxaglate versus iopromide] [1996.05]

Iodixanol in leg phlebography: a randomized, double-blind parallel group phase III trial comparing iodixanol to ioxaglate. [1996.03]

Immediate and late adverse reactions in coronary angiography. A comparison between iodixanol and ioxaglate. [1996.03]

Nephrotoxicity of ioxaglate and ioversol assessed by glomerular filtration rate: a pilot study. [1996.02]

A double-blind CT study comparing the safety and efficacy of iopentol and ioxaglate in paediatric patients. [1996]

Other possibly related research studies

Allergic reaction to contrast medium following gastric band adjustment. [2007.10]

Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. [2007.10.01]

Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. [2006.11]

Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty. [2006.06]

N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial. [2005.06]

Ultrasound findings of iodide mumps. [2005.02]

Role of osmolality of contrast media in the development of post-ERCP pancreatitis: a metanalysis. [2004.03]

No difference among modern contrast media's effect on neointimal proliferation and restenosis after coronary stenting in pigs. [2003.12]

Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy. [2003.12]

Inflammatory markers increase following exposure to radiographic contrast media. [2003.09]

Glaucoma as a complication of superselective ophthalmic angiography. [2003.09]

Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells. [2003.08]

Review article: Effects of radiographic contrast media on the lung. [2003.05]

Roles of intracellular Ca2+ and cyclic AMP in mast cell histamine release induced by radiographic contrast media. [2003.04]

A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. [2003.03]

[Iodic allergic reaction with vasospasm occluded coronary during coronarography] [2002.12]

Allergies correlated to adverse reactions induced by non-ionic monomeric and ionic dimeric contrast media for contrast enhanced CT examination. [2002.09]

Effects of an acute dose of L-arginine during coronary angiography in patients with chronic renal failure: a randomized, parallel, double-blind clinical trial. [2003.03]

Effects of gentamicin, lipopolysaccharide, and contrast media on immortalized proximal tubular cells. [2002.11]

Comparative tolerability of contrast media used for coronary interventions. [2002]

[Specific antibodies to iodinated contrast media. Research techniques, specificity] [2002.09]

Effects of gentamicin, lipopolysaccharide, and contrast media on immortalized proximal tubular cells. [2002.09]

Effect of an ionic compared to a non-ionic X-ray contrast agent on platelets and coagulation during diagnostic cardiac catheterisation. [2002.05]

The increased histamine release in ischaemic heart disease patients undergoing coronaroangiography is not mediated by specific IgE. [2002]

Do clinically relevant circulating concentrations of radiographic contrast agents inhibit platelet-dependent arterial thrombosis? [2002.03.01]

Monte Carlo dose simulation for intracoronary radiation therapy with a rhenium 188 solution-filled balloon with contrast medium. [2002.05]

A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes. [2000.03.15]

Ultrastructural evaluation of the effects of the contrast media on the rat kidney. [2001.10]

Effects of radiographic contrast media on pulmonary vascular resistance of normoxic and chronically hypoxic pulmonary hypertensive rats. [2001.12]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014